FIELD: medicine. SUBSTANCE: method involves introducing viscous protector into the anterior chamber filling the whole angle of the anterior chamber and pupil zone. Anterior chamber cyst wall is accessed w erbium-YAG-endolaser. Cyst growth zone is coagulated using endolasercoagulater device. EFFECT: high reliability in insulating anterior chamber and pupil zone; reduced risk of toxic neuroretinitis to occur.
Authors
Dates
2002-01-27—Published
1999-11-10—Filed